Home » Topics » Regulatory

Regulatory
RSS

Abilify sNDA submitted for long-term treatment of schizophrenia

Feb. 27, 2003

Approval sought for once-daily Reminyl

Feb. 27, 2003

Label for Botox widened in Europe

Feb. 27, 2003

Viread recommended for approval in E.U. for use in treatment-naive HIV patients

Feb. 26, 2003

CPMP recommends approval of Remicade for ankylosing spondylitis, label expansion

Feb. 26, 2003

Metformin XT NDA accepted for filing by FDA

Feb. 24, 2003

Eligard 30 mg receives FDA approval

Feb. 20, 2003

Approvable letter issued for Zelapar

Feb. 20, 2003

Effexor XR approved for social anxiety disorder

Feb. 14, 2003

Bayer seeks expansion of aspirin labeling to include prevention of first heart attack

Feb. 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...